- Corporate Officers - H
- Hopfner Robert Lorne
Insider Trading History of Hopfner Robert Lorne
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hopfner Robert Lorne since 2020.
This trader's CIK number is 1551966.
At the time of last reporting, Hopfner Robert Lorne was the Officer of Inozyme Pharma, Inc.. (stock ticker symbol INZY).
Also see all insider trading activities at Inozyme Pharma, Inc..
Note that in the past
Hopfner Robert Lorne also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Rallybio Corp (RLYB) by Hopfner Robert Lorne
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | RLYB | 576,923 | $7,499,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vaxcyte, Inc. (PCVX) by Hopfner Robert Lorne
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | PCVX | 0 | $0 | 817,549 | $22,130,793 | 0 | $0 |
| 2020 | PCVX | 93,000 | $1,488,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inozyme Pharma, Inc. (INZY) by Hopfner Robert Lorne
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | INZY | 1,833,697 | $9,254,774 | 0 | $0 | 0 | $0 |
| 2022 | INZY | 1,070,000 | $3,948,300 | 0 | $0 | 0 | $0 |
| 2020 | INZY | 187,500 | $3,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Hopfner Robert Lorne:
1. Rallybio Corp (RLYB)
2. Vaxcyte, Inc. (PCVX)
3. Inozyme Pharma, Inc. (INZY)
Table 1. Insider trading of Rallybio Corp (RLYB) by Hopfner Robert Lorne
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-08-02 | RLYB | Buy | 576,923 | 13.00 | 7,499,999 |
Table 2. Insider trading of Vaxcyte, Inc. (PCVX) by Hopfner Robert Lorne
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-02-08 | PCVX | Sale | 79,796 | 25.85 | 2,062,726 |
| 2021-02-09 | PCVX | Sale | 220,744 | 27.98 | 6,176,417 |
| 2021-02-10 | PCVX | Sale | 78,158 | 27.21 | 2,126,522 |
| 2021-02-03 | PCVX | Sale | 2,768 | 25.06 | 69,366 |
| 2021-02-02 | PCVX | Sale | 14,234 | 25.13 | 357,700 |
| 2021-01-28 | PCVX | Sale | 2,000 | 25.07 | 50,140 |
| 2021-01-25 | PCVX | Sale | 34,972 | 25.84 | 903,676 |
| 2021-01-26 | PCVX | Sale | 18,142 | 25.68 | 465,886 |
| 2021-01-27 | PCVX | Sale | 2,140 | 25.30 | 54,142 |
| 2021-01-20 | PCVX | Sale | 19,046 | 25.35 | 482,816 |
| 2021-01-21 | PCVX | Sale | 100 | 25.11 | 2,511 |
| 2021-01-22 | PCVX | Sale | 11,383 | 25.16 | 286,396 |
| 2021-01-19 | PCVX | Sale | 49,516 | 25.80 | 1,277,512 |
| 2021-01-14 | PCVX | Sale | 14,918 | 25.88 | 386,077 |
| 2021-01-15 | PCVX | Sale | 26,677 | 25.89 | 690,800 |
| 2021-01-13 | PCVX | Sale | 29,110 | 26.12 | 760,353 |
| 2021-01-12 | PCVX | Sale | 18,567 | 26.70 | 495,738 |
| 2021-01-11 | PCVX | Sale | 49,666 | 26.38 | 1,310,040 |
| 2021-01-06 | PCVX | Sale | 57,420 | 29.61 | 1,700,493 |
| 2021-01-07 | PCVX | Sale | 47,580 | 28.69 | 1,364,927 |
| 2021-01-08 | PCVX | Sale | 40,612 | 27.25 | 1,106,555 |
| 2020-06-16 | PCVX | Buy | 93,000 | 16.00 | 1,488,000 |
Table 3. Insider trading of Inozyme Pharma, Inc. (INZY) by Hopfner Robert Lorne
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-08-01 | INZY | Buy | 833,333 | 4.80 | 3,999,998 |
| 2023-05-12 | INZY | Buy | 228,702 | 6.25 | 1,429,387 |
| 2023-05-11 | INZY | Buy | 219,230 | 6.48 | 1,420,610 |
| 2023-03-29 | INZY | Buy | 344,592 | 4.54 | 1,563,758 |
| 2023-03-27 | INZY | Buy | 51,074 | 3.69 | 188,718 |
| 2023-03-28 | INZY | Buy | 156,766 | 4.16 | 652,303 |
| 2022-04-19 | INZY | Buy | 1,070,000 | 3.69 | 3,948,300 |
| 2020-07-28 | INZY | Buy | 187,500 | 16.00 | 3,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hopfner Robert Lorne
(Officer of Inozyme Pharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.